Analysts are positive about Glencore shares
From a total of 13 analysis of the Glencore shares issued this past 12 months, 10 were buy, two hold and one sell. The average closing price of the Glencore stock for the last 200 trading days is currently $223.9 (£166.37). The last closing price of $285.06 (£211.85) thus deviates by +27.34 percent, which corresponds to a “buy” valuation from a chart perspective.
In the last twelve months, a total of 13 analyst ratings were issued for the Glencore shares. Of these, 10 were “Buy”, two “Hold” and one “Sell”. In summary, that results in a “Buy” rating for Glencore stock. No analyst updates on Glencore are available from last month.
Within the framework of the ratings carried out by the analysts, the average target price was $291.9 (£217.22). The stock thus has an upside potential of 2.54 percent based on the last closing price $282.6 (£211.85). This is the basis for a “Hold” recommendation. The bottom line is that Glencore receives a “Buy” rating for this point of the analysis.
If you want to find more details about the company Glencore and what analysts think of its share price, and to find the latest mining news in the world, download for free the Mining News app.
How investors judge Glencore
The investor mood at Glencore in the discussion forums and opinion columns of the social media is particularly positive overall. This is reflected in the statements and opinions of the past two weeks, which we have evaluated for you in order to gain a further valuation factor for the share. It became apparent that the discussions in the past few days focused in particular on negative topics, which means that the share is rated “Hold” overall.
Finally, this form of analysis has been enriched by concretely predictable trading signals from social media. This revealed 6 sell and 0 buy signals. From this picture, in turn, a “sell” recommendation can be derived at this level. In this estimation, this results in a “Hold” in terms of investor sentiment.
Glencore: How do chart analysts judge?
The average closing price of the Glencore share for the last 200 trading days is currently $223.9 (£166.37). The last closing price of $285.06 (£211.85) thus deviates by +27.34 percent, which corresponds to a “buy” valuation from a chart perspective. Let’s look at the average of the last 50 trading days. For this $236 (£175.42) the last closing price is also above the moving average (+20.77 percent deviation). The Glencore stock is thus also given a “buy” rating on this shorter-term basis. The bottom line is that the Glencore share thus receives a “Buy” rating for the simple chart technique.
Shareholders can draw hope thanks to RSI
A well-known tool used in technical analysis to assess whether a stock is currently “overbought” or “oversold” is the Relative Strength Index (RSI). This index relates to price movements over time. Analysts consider the RSI on a 7-day and 25-day basis for Glencore. Let’s start with the 7-day RSI, which currently stands at 14.8 points. This means that Glencore is currently oversold. The share is therefore classified as a “Buy”. What does the 25-day RSI look like? Glencore is also oversold (value 23.99), so the stock is also given a “Buy” rating for the RSI25. Glencore is thus rated “Buy” for this point in the analysis.
(Featured image by geralt via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in finanz trends, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [Week 12]
Empires come in all shapes and sizes, from small upstart affiliate businesses right through to world-dominating empires like TikTok. And...
Green Technologies: Why Southeast Asia is the New Global Investment Frontier
According to a report by the United Nations Environment Program, annual green funding flows in Southeast Asia have been estimated...
Eniax Signs Cerba, Analiza, and Oftalvist as Clients and Aims for 1M in Sales in 2023
Eniax also works with some medical centers in Spain, such as the HLA Moncloa University Hospital in Madrid, from Grupo...
GreenIT and Copenhagen Infrastructure to Develop Three 2 GW Offshore Wind Farms
GreenIT was established in March 2021 and is dedicated to the development, construction, and operation of plants for the production...
Concrete Investing Launches €4.75 Million Crowdfunding Campaign
Concrete Investing has financed 24 real estate transactions to date in four years of activity, with about €46 million raised,...
Featured2 weeks ago
Rice Demand for Exports Was Slow to Moderate
Crowdfunding3 days ago
Concrete Investing Launches €4.75 Million Crowdfunding Campaign
Mining & Energy1 week ago
With the Copper Crunch Still Looming, Keep an Eye on Trigon Metals
Biotech5 days ago
Arthex Biotech Raises €11 Million to Advance Against Muscular Dystrophy